Synthetic lethality of KDM1A and mTOR inhibitors: A novel combination therapy for endometrial cancer

被引：0

作者：

Pitta-Venkata, Prabhakar ^{[1
]}

Palacios, Bridgitte ^{[1
]}

Chen, Yihong ^{[1
]}

Viswanadhapalli, Suryavathi ^{[1
]}

Pratap, Uday P. ^{[1
]}

Luo, Yiliao ^{[1
]}

Li, Mengxing ^{[1
]}

Altwegg, Kristin ^{[1
]}

Li, Xiaonan ^{[1
]}

Suzuki, Takayoshi ^{[2
]}

Tekmal, Rajeshwar Rao ^{[1
]}

Kost, Edward ^{[1
]}

Sareddy, Gangadhara Reddy ^{[1
]}

机构：

[1] UT Hlth San Antonio, San Antonio, TX USA

[2] Kyoto Prefectural Univ Med, Kyoto, Japan

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2019-280

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

280

引用

页数：2

共 50 条

[11] LSD1/KDM1A inhibitors in clinical trials: advances and prospects [J].

Fang, Yuan ;

Liao, Guochao ;

Yu, Bin .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)

[12] Targeting Histone Lysine Demethylase LSD1/KDM1A as a New Avenue for Cancer Therapy [J].

Fang, Yuan ;

Liao, Guochao ;

Yu, Bin .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (11) :889-891

[13] A novel multi-functional KDM1A chemoprobe as a tool for clinical cancer research. [J].

Ciceri, Filippo ;

Lunardi, Serena ;

Mascaro, Cristina ;

Rodriguez, Raquel Ruiz ;

Carceller, Elena ;

Ortega, Alberto .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

[14] Polymyxins and quinazolines are LSD1/KDM1A inhibitors with unusual structural features [J].

Speranzini, Valentina ;

Rotili, Dante ;

Ciossani, Giuseppe ;

Pilotto, Simona ;

Marrocco, Biagina ;

Forgione, Mariantonietta ;

Lucidi, Alessia ;

Forneris, Federico ;

Mehdipour, Parinaz ;

Velankar, Sameer ;

Mai, Antonello ;

Mattevi, Andrea .

SCIENCE ADVANCES, 2016, 2 (09)

[15] Synthetic lethality in personalized cancer therapy [J].

Ying Pang ;

Meng Cheng ;

Mu Chen ;

Kaijun Zhao ;

Yuanyuan Yin ;

Min Liu ;

Jing Zhang ;

Chunlong Zhong .

Genome Instability & Disease, 2023, 4 (2) :121-135

[16] Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors [J].

Lord, Christopher J. ;

Tutt, Andrew N. J. ;

Ashworth, Alan .

ANNUAL REVIEW OF MEDICINE, VOL 66, 2015, 66 :455-470

[17] Combination therapy with mTOR and PI3 kinase inhibitors is broadly synergistic in a wide variety of endometrial cancer cells [J].

Yang, Shujie ;

Xiao, Xue ;

Meng, Xiangbing ;

Leslie, Kimberly K. .

CANCER RESEARCH, 2011, 71

[18] Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia Models [J].

Romussi, Alessia ;

Cappa, Anna ;

Vianello, Paola ;

Brambillasca, Silvia ;

Cera, Maria Rosaria ;

Dal Zuffo, Roberto ;

Faga, Giovanni ;

Fattori, Raimondo ;

Moretti, Loris ;

Trifiro, Paolo ;

Villa, Manuela ;

Vultaggio, Stefania ;

Cecatiello, Valentina ;

Pasqualato, Sebastiano ;

Dondio, Giulio ;

So, Chi Wai Eric ;

Minucci, Saverio ;

Sartori, Luca ;

Varasi, Mario ;

Mercurio, Ciro .

ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (05) :754-759

[19] Metabolic synthetic lethality in cancer therapy [J].

Zecchini, Vincent ;

Frezza, Christian .

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2017, 1858 (08) :723-731

[20] A new cancer therapy strategy: Synthetic lethality induced by inhibition of mTOR and cMYC and JNK activation [J].

Chen, Hui ;

Rivera, Jason ;

Paradise, Marc ;

Xu, Zihan ;

Mognol, Giuliana ;

Varner, Judith .

CANCER RESEARCH, 2024, 84 (06)

← 1 2 3 4 5 →